Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis E vaccines: progress and prospects.

Harald Claus Worm1, Gerhard Wirnsberger

  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University Clinic Graz, Auenbruggerplatz 15, A-8036 Graz, Austria. harald.worm@klinikum-graz.at

Drugs
|July 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of fall recurrence among persistent, quasi-persistent, and transient fallers: a 3-year analysis from the SCOPE study.

European geriatric medicine·2026
Same author

Statin use does not impair muscle health in older adults: findings from the SCOPE study.

Aging clinical and experimental research·2026
Same author

[Lithium and its impact on renal function. Recommendations for practice, especially for older patients].

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater·2025
Same author

Characteristics of Falls among Community-Dwelling Older Adults: The SCOPE Study.

Gerontology·2025
Same author

Associations between plasma osteopontin, sex, and 2-year global and cardiorenal outcomes in older outpatients screened for CKD: a secondary analysis of the SCOPE study.

Clinical kidney journal·2024
Same author

Healthcare costs in relation to kidney function among older people: the SCOPE study.

European geriatric medicine·2024

Hepatitis E virus (HEV) infection is a significant global health issue, causing epidemics and acute liver failure. Developing an effective HEV vaccine is crucial due to widespread susceptibility.

Area of Science:

  • Hepatology
  • Virology
  • Vaccinology

Background:

  • Hepatitis E virus (HEV) is a major cause of enterically transmitted hepatitis globally.
  • HEV infection leads to epidemics in developing countries and contributes significantly to acute liver failure.
  • High susceptibility rates highlight the need for an effective Hepatitis E vaccine.

Purpose of the Study:

  • To review the current status and challenges in developing a vaccine against Hepatitis E virus (HEV).
  • To discuss the public health significance of HEV infection and the rationale for vaccine development.

Main Methods:

  • Review of HEV characteristics, epidemiology, and pathogenesis.
  • Analysis of current vaccine development strategies, including recombinant protein-based and DNA-based approaches.

Related Experiment Videos

  • Evaluation of preclinical and clinical trial data for HEV vaccines.

    • Main Results:

    • HEV does not grow well in cell culture, hindering traditional vaccine production.
    • Recombinant protein-based vaccines have shown promise, inducing neutralizing antibodies and protection in non-human primates.
    • One HEV vaccine candidate has progressed to Phase I trials and is undergoing field evaluation.

    Conclusions:

    • Despite promising results, further research is needed before widespread HEV vaccination programs can be implemented.
    • Developing an effective Hepatitis E vaccine remains a critical public health priority.
    • Addressing remaining questions is essential for the successful deployment of HEV vaccines.